Breaking Diabetes News
From stem cells to billions of human insulin-producing cells
Giant step toward new diabetes treatment

Harvard Stem Cell Institute Co-director Doug Melton today announced that his lab has made a giant leap forward in the quest to find a truly effective treatment for type 1 diabetes, a condition that affects an estimated 3 million Americans at a cost of about $15 billion annually.

With human embryonic stem cells as a starting point, the scientists are for the first time able to produce, in the kind of massive quantities needed for cell transplantation and pharmaceutical purposes, human insulin-producing beta cells equivalent in most every way to normally functioning beta cells. Read and share the whole story.
Archive: One Harvard Scientist's Quest To Find A Cure For His Kids
Doug Melton's story told by WBUR in spring 2013

"Many scientists believe that human embryonic stem cells - basic cells that can develop into any tissue or organ in the body - hold the key to curing diseases like cancer, diabetes, and Parkinson's disease. In this installment of our Visionaries series, we take a look at the work of a man who has spent his career harnessing the power of stem cells to heal patients."
Research Updates
Blood Program
"Groundbreaking" barcoding tool for stem cells questions how our day-to-day blood supply is generated

Blood Program
A non-toxic strategy to treat leukemia: Harvard/MIT team finds that killing cancer cells by disrupting their metabolism doesn't harm normal cells
Media Mentions
9/15/14
New York Times
HSCI is featured in an article about the trials of stem cell therapy. Co-director David Scadden is quoted.
Stem Cell Lines
Fall 2014 


Copyright � 2014. All Rights Reserved.